Pacira BioSciences (PCRX) Tax Rate (2013 - 2026)
Pacira BioSciences (PCRX) recorded quarterly Tax Rate of 41.66% in Q1 2026, up 122.31% quarter-over-quarter from 186.69% in Q4 2025, and down 307.0% on a YoY basis from 20.12% in Q1 2025.
Pacira BioSciences (PCRX) Tax Rate (2013 - 2026) Analysis & Trends
Pacira BioSciences' Tax Rate history runs 14 years deep, the most recent figure standing at 41.66% for Q1 2026.
- In Q1 2026, Tax Rate fell 307.0% year-over-year to 41.66%; the TTM figure through Mar 2026 stood at 60.98% (up 11343.0% YoY), while the FY2025 annual figure was 58.31%, up 11608.0% from the prior year.
- Tax Rate was 41.66% for Q1 2026 at Pacira BioSciences, up from 186.69% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 133.49% in Q3 2022 to a low of 186.69% in Q4 2025.
- Historically, Tax Rate has averaged 12.95% across 5 years, with a median of 34.17% in 2024.
- The sharpest annual moves came in 2022 and 2025: Tax Rate jumped 10638 bps in 2022, then tumbled 22385 bps in 2025.
- A 5-year view of Tax Rate shows it stood at 44.09% in 2022, then tumbled by 40 bps to 26.25% in 2023, then surged by 42 bps to 37.16% in 2024, then sank by 602 bps to 186.69% in 2025, then surged by 122 bps to 41.66% in 2026.
- The last three Tax Rate figures came in at 41.66% (Q1 2026), 186.69% (Q4 2025), and 42.97% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 15.33% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 20.71% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 13.63% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -20.44% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 19.81% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 34.48% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -7.43% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 9.29% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 24.29% |
| 10 | Pacira BioSciences | 940.31 Mn | 738.13 Mn | 140.96 Mn | 41.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.66% |
| Mar 31, 2026 | 41.66% |
| Dec 31, 2025 | -186.69% |
| Dec 31, 2025 | -186.69% |
| Sep 30, 2025 | 42.97% |
| Sep 30, 2025 | 42.97% |
| Jun 30, 2025 | -151.53% |
| Jun 30, 2025 | -151.53% |
| Mar 31, 2025 | 44.73% |
| Mar 31, 2025 | 44.73% |
| Dec 31, 2024 | 37.16% |
| Dec 31, 2024 | 37.16% |
| Sep 30, 2024 | -3.32% |
| Sep 30, 2024 | -3.32% |
| Jun 30, 2024 | 48.38% |
| Jun 30, 2024 | 48.38% |
| Mar 31, 2024 | 34.17% |
| Mar 31, 2024 | 34.17% |
| Dec 31, 2023 | 26.25% |
| Dec 31, 2023 | 26.25% |